UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Current pharmaceutical design, 2012-12, Vol.18 (37), p.6043-6052

2012

Volltextzugriff (PDF)

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

The New England journal of medicine, 2016-04, Vol.374 (14), p.1356-1367

2016

Volltextzugriff (PDF)

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Annals of oncology, 2020-11, Vol.31 (11), p.1553-1560

2020

Volltextzugriff (PDF)

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

The New England journal of medicine, 2016-07, Vol.375 (2), p.134-142

2016

Volltextzugriff (PDF)

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4189-4198

2011

Volltextzugriff (PDF)

ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients

Supportive care in cancer, 2019-01, Vol.27 (1), p.87-95

2019

Volltextzugriff (PDF)

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

Annals of oncology, 2012-08, Vol.23 (8), p.1986-1992

2012

Volltextzugriff (PDF)

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis

International journal of clinical oncology, 2021-01, Vol.26 (1), p.1-17

2021

Volltextzugriff (PDF)

Nausea and Vomiting in 2021: A Comprehensive Update

Journal of clinical gastroenterology, 2021-04, Vol.55 (4), p.279-299

2021

Volltextzugriff (PDF)

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy

Cochrane database of systematic reviews, 2015-11, Vol.2021 (11), p.CD009464

2015

Volltextzugriff (PDF)

Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review

Annals of oncology, 2015-06, Vol.26 (6), p.1081-1090

2015

Volltextzugriff (PDF)

Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed

Current medical research and opinion, 2006-12, Vol.22 (12), p.2403-2410

2006

Volltextzugriff (PDF)

Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline

Pediatric blood & cancer, 2022-12, Vol.69 (12), p.e30001-n/a

2022

Volltextzugriff (PDF)

Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review

Critical reviews in food science and nutrition, 2017-01, Vol.57 (1), p.141-146

2017

Volltextzugriff (PDF)

Metagenomics and chemotherapy‐induced nausea: A roadmap for future research

Cancer, 2022-02, Vol.128 (3), p.461-470

2022

Volltextzugriff (PDF)

Practice Patterns for Prevention of Chemotherapy‐Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real‐World Prescribing Data

The oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.e1073-e1082

2021

Volltextzugriff (PDF)

Aprepitant and Fosaprepitant: A 10‐Year Review of Efficacy and Safety

The oncologist (Dayton, Ohio), 2015-04, Vol.20 (4), p.450-458

2015

Volltextzugriff (PDF)

Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis

Cochrane database of systematic reviews, 2021-11, Vol.11 (1), p.CD012775

2021

Volltextzugriff (PDF)

CINV: still troubling patients after all these years

Supportive care in cancer, 2018-03, Vol.26 (Suppl 1), p.5-9

Aapro, Matti

2018

Volltextzugriff (PDF)

Opioid induced nausea and vomiting

European journal of pharmacology, 2014-01, Vol.722, p.67-78

2014

Volltextzugriff (PDF)

Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)

European journal of cancer (1990), 2022-05, Vol.166, p.126-133

2022

Volltextzugriff (PDF)

The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting

European journal of pharmacology, 2014-01, Vol.722, p.48-54

2014

Volltextzugriff (PDF)

A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics

American journal of therapeutics, 2010-09, Vol.17 (5), p.476-486

Hsu, Eric S

2010

Volltextzugriff (PDF)

Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study

Journal of pain and symptom management, 2014-05, Vol.47 (5), p.839-848.e4

2014

Volltextzugriff (PDF)

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

Annals of oncology, 2018-02, Vol.29 (2), p.452-458

2018

Volltextzugriff (PDF)

1 – 25 von 1.625

Suche als RSS-Feed

Aktive Filter

ThemaAntiemetics - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.479)
Mit Volltextzugriff
(1.137)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.599)
Nausea - Chemically Induced
(1.413)
Vomiting - Chemically Induced
(1.374)
Science & Technology
(1.194)
Life Sciences & Biomedicine
(1.190)
Antineoplastic Agents - Adverse Effects
(947)
Female
(911)
Vomiting - Prevention & Control
(866)
Nausea - Prevention & Control
(851)
Male
(755)
Oncology
(736)
Middle Aged
(713)
Adult
(649)
Nausea - Drug Therapy
(607)
Nausea
(600)
Vomiting - Drug Therapy
(542)
Aged
(540)
Chemotherapy
(534)
Vomiting
(512)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Supportive Care In Cancer
(229)
Gan To Kagaku Ryoho
(47)
Annals Of Oncology
(39)
Journal Of Clinical Oncology
(37)
European Journal Of Cancer
(32)
Oncology
(28)
Cancer
(24)
Drugs
(21)
Cancer Chemotherapy And Pharmacology
(17)
Journal Of Pain And Symptom Management
(17)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Non-analgesic effects of opioids: opioid-induced nausea and vomiting: mechanisms and strategies for their limitation

Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015 Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis

Nausea and Vomiting in 2021: A Comprehensive Update

Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy

Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review

Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed

Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline

Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review

Metagenomics and chemotherapy‐induced nausea: A roadmap for future research

Practice Patterns for Prevention of Chemotherapy‐Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real‐World Prescribing Data

Aprepitant and Fosaprepitant: A 10‐Year Review of Efficacy and Safety

Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis

CINV: still troubling patients after all these years

Opioid induced nausea and vomiting

Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)

The cellular mechanisms of the antiemetic action of dexamethasone and related glucocorticoids against vomiting

A review of granisetron, 5-hydroxytryptamine3 receptor antagonists, and other antiemetics

Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

Aktive Filter

Suchergebnisse filtern